Regulation - Vibativ

Filter

Current filters:

Vibativ

Popular Filters

Mixed FDA panel vote for Theravance's Vibativ for nosocomial pneumonia

03-12-2012

US drug developer Theravance (Nasdaq: THRX) saw its shares rise more than 5% $22.48 by close of trading…

Antibiotics and Infectious diseasesPharmaceuticalRegulationTheravanceVibativ

Astellas get EU approval for Vibativ for nosocomial pneumonia caused by MRSA

15-09-2011

The European Commission has granted marketing authorization for Japanese drug major Astellas’ (TYO:…

Antibiotics and Infectious diseasesAstellas PharmaEuropePharmaceuticalRegulationTheravanceVibativ

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top